BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 23347652)

  • 1. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications.
    Ha SY; Lee SE; Kwon MJ; Kim YJ; Lee EH; Seo J; Jang KT; Lee J; Choi YL
    Hum Pathol; 2013 Jul; 44(7):1300-9. PubMed ID: 23347652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of t(17;22)(q22;q13) (COL1A1/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays.
    Segura S; Salgado R; Toll A; Martín-Ezquerra G; Yébenes M; Sáez A; Solé F; Barranco C; Umbert P; Espinet B; Pujol RM
    Hum Pathol; 2011 Feb; 42(2):176-84. PubMed ID: 21111450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
    Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
    Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas.
    Szollosi Z; Scholtz B; Egervari K; Nemes Z
    J Clin Pathol; 2007 Feb; 60(2):190-4. PubMed ID: 16731589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of COL1A1-PDGFB fusion gene detection by fluorescence in situ hybridization in biopsy tissue of dermatofibrosarcoma protuberans.
    Zhang Z; Chen H; Chen M; He X; Wang Y; Zhang H
    J Dermatol; 2017 Jul; 44(7):798-802. PubMed ID: 28150334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans.
    Kutzner H; Mentzel T; Palmedo G; Hantschke M; Rütten A; Paredes BE; Schärer L; Guillen CS; Requena L
    Am J Surg Pathol; 2010 Feb; 34(2):190-201. PubMed ID: 20061935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans.
    Macarenco RS; Zamolyi R; Franco MF; Nascimento AG; Abott JJ; Wang X; Erickson-Johnson MR; Oliveira AM
    Genes Chromosomes Cancer; 2008 Mar; 47(3):260-5. PubMed ID: 18069662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel fusion gene of collagen type I alpha 1 (exon 31) and platelet-derived growth factor B-chain (exon 2) in dermatofibrosarcoma protuberans.
    Nakanishi G; Lin SN; Asagoe K; Suzuki N; Matsuo A; Tanaka R; Makino E; Fujimoto W; Iwatsuki K
    Eur J Dermatol; 2007; 17(3):217-9. PubMed ID: 17478383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
    Mentzel T; Schärer L; Kazakov DV; Michal M
    Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants.
    Jahanseir K; Xing D; Greipp PT; Sukov WR; Keeney GL; Howitt BE; Schoolmeester JK
    Int J Gynecol Pathol; 2018 Nov; 37(6):537-546. PubMed ID: 29140881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diagnosis of dermatofibrosarcoma protuberans: a comparison between reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization methodologies.
    Salgado R; Llombart B; M Pujol R; Fernández-Serra A; Sanmartín O; Toll A; Rubio L; Segura S; Barranco C; Serra-Guillén C; Yébenes M; Salido M; Traves V; Monteagudo C; Sáez E; Hernández T; de Álava E; Llombart-Bosch A; Solé F; Guillén C; Espinet B; López-Guerrero JA
    Genes Chromosomes Cancer; 2011 Jul; 50(7):510-7. PubMed ID: 21484928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
    Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
    J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and clinicopathological analysis of dermatofibrosarcoma protuberans.
    Walluks K; Chen Y; Woelfel C; Yang L; Cui T; Seliger C; Geier C; Knösel T; Hauke S; Petersen I
    Pathol Res Pract; 2013 Jan; 209(1):30-5. PubMed ID: 23207290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudocystic dermatofibrosarcoma protuberans: report of two cases and demonstration of COL1A1-PDGFB rearrangement.
    Shvartsbeyn M; Lazar AJ; Lopez-Terrada D; Meehan SA
    J Cutan Pathol; 2012 Mar; 39(3):356-60. PubMed ID: 22335595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin.
    Wang WL; Patel KU; Coleman NM; Smith-Zagone MJ; Ivan D; Reed JA; López-Terrada D; Lazar AJ; Prieto VG
    Am J Dermatopathol; 2010 Apr; 32(2):149-53. PubMed ID: 19940748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans.
    Wang J; Morimitsu Y; Okamoto S; Hisaoka M; Ishida T; Sheng W; Hashimoto H
    J Mol Diagn; 2000 Feb; 2(1):47-52. PubMed ID: 11272901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implications.
    Llombart B; Sanmartín O; López-Guerrero JA; Monteagudo C; Serra C; Requena C; Poveda A; Vistós JL; Almenar S; Llombart-Bosch A; Guillén C
    Histopathology; 2009 Jun; 54(7):860-72. PubMed ID: 19635106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors].
    Bianchini L; Maire G; Pedeutour F;
    Bull Cancer; 2007 Feb; 94(2):179-89. PubMed ID: 17337387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatofibrosarcoma Protuberans of Distal Extremities and Acral Sites: A Clinicopathologic Analysis of 27 Cases.
    Shah KK; McHugh JB; Folpe AL; Patel RM
    Am J Surg Pathol; 2018 Mar; 42(3):413-419. PubMed ID: 29240584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatofibrosarcoma protuberans of the face: A clinicopathologic and molecular study of 34 cases.
    Han Q; Chen M; Yang J; Du T; Peng H
    J Dtsch Dermatol Ges; 2022 Nov; 20(11):1463-1473. PubMed ID: 36377270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.